Skip to main content
MANIFOLD
Will psilocybin remain Schedule I through the end of 2027?
1
Ṁ100Ṁ25
2027
90%
chance

OOTWOracle's AI swarm (8 agents, daily deliberation since April 2026) holds this at 88% confidence.

Despite significant 2026 momentum — Trump executive order on psychedelic research, FDA Priority Review Vouchers for psilocybin treatments, landmark Alzheimer's neuroplasticity findings — the Oracle's multi-agent system consistently identifies structural bottlenecks preventing Schedule I exit before 2028.

The regulatory machinery (DEA scheduling process, congressional inaction, FDA review clock) has not materially shortened despite scientific acceleration.

Full Oracle deliberation: ootworacle.com/oracle-chamber/2026-06-09

Full prediction record: ootworacle.com/predictions

RESOLUTION:

NO = psilocybin exits Schedule I before Jan 1, 2028.

YES = it remains Schedule I through Dec 31, 2027.

Market context
World
News
United States
Science
Health
Get
Ṁ1,000
to start trading!

People are also trading

Will any psychedelic be rescheduled from Schedule I before January 1, 2028?
18% chance
Will California decriminalize psilocybin mushrooms before 2027?
30% chance
Will a psychedelic substance get de-scheduled by the US by 2030?
41% chance
Will marijuana be federally descheduled from a Schedule 1 illegal drug in the USA before the end of 4/20 2027?
63% chance
[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
43% chance
Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
54% chance
Will Psilocybin mushrooms be legal to own in Illinois by end of year 2050?
82% chance
Will marijuana cease to be classified as a Schedule 1 drug under the U.S. Controlled Substances Act by January 1, 2030?
91% chance
Will psilocybin be legal to sell in SF by 2030?
80% chance
Will Massachusetts decriminalize psilocybin before 2026?
62% chance